Benjamin Humpherys, DO
Pain Medicine · Layton, UTNPI 1891728036
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $108,486 of the $119,669 with a category attached, or 90.7%. AbbVie accounts for 95.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $24,729 and has fallen 52.8% since, to $11,666 in 2025. Among pain medicine clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $529.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$114K
- International Rehabilitative Sciences, Inc$4K
- Abbott$370
- Boston Scientific$324
- Medtronic$178
- Lilly USA, LLC$113
- plus $826 from 18 others
What the payments were for
- Speaking & faculty fees$108,48691%
- Travel & lodging$3,2043%
- Food & beverage$4,2094%
- Other$3,7693%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 153 | $114,074 |
| International Rehabilitative Sciences, Inc | 2 | $3,783 |
| Abbott | 2 | $370 |
| Boston Scientific | 10 | $324 |
| Medtronic(2 entities) | 10 | $178 |
| Lilly USA, LLC | 9 | $113 |
| SPR Therapeutics, Inc | 1 | $97 |
| Stimwave Technologies Incorporated | 5 | $91 |
| Nalu Medical, Inc. | 4 | $88 |
| Relievant Medsystems, Inc. | 3 | $84 |
| Pfizer | 6 | $83 |
| Si-bone, Inc. | 4 | $74 |
| Arbor Pharmaceuticals, Inc. | 3 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Amgen | 2 | $38 |
| Averitas Pharma Inc. | 1 | $33 |
| Azurity Pharmaceuticals, Inc. | 2 | $29 |
| Saluda Medical Americas, Inc. | 1 | $26 |
| ABC Home Medical Supply, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| 180 Medical, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$112,133
- RS 4i Plus Sequential Stimulator$3,769
- RS-LBG, RS-SG, RS-FBG$3,769
- Lamitrode SCS Leads$370
- SPECTRA WAVEWRITER$165
How this compares
$119,669 in reported general payments places this provider in the 95th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $582 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 19 | $233 |
| Gabapentin | 16 | $139 |
| Diazepam | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Layton
- Joshua ShepherdLayton$4K
- Kathryn NelsonLayton$2K
- Maria SchwartzSalt Lake City$813K
- Jeremy JoyalDraper$170K
- Lynn WebsterSalt Lake City$160K
- Derek HaightDraper$78K
- Jon ObraySt George$24K
- Jason BeckstrandWest Jordan$17K
- Austin AlbrightSalt Lake City$14K
- Jeffrey PenceWest Valley City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.